{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T13:51:50Z","timestamp":1753883510516,"version":"3.41.2"},"reference-count":43,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"11","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Glob Oncol"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n            <jats:title>PURPOSE<\/jats:title>\n            <jats:p>Previous studies have shown differences in patient profile and outcomes depending on the source of health care funding. Here, we evaluated the overall survival (OS) of patients with bladder cancer in public and in private systems in S\u00e3o Paulo, Brazil.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS<\/jats:title>\n            <jats:p>We conducted a retrospective cohort study of patients with bladder cancer registered in the Registro Hospitalar de C\u00e2ncer da Funda\u00e7\u00e3o Oncocentro de S\u00e3o Paulo, a large state-wide database. Eligibility required a diagnosis of non\u2013muscle-invasive or invasive bladder cancer between 2013 and 2018. The main objective was to compare OS between private and public treatment-funding sources.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>\n              Of 21,090 patients with bladder cancer since database inception, 6,217 were eligible (82.4% with a public source of health care funding). Patients with a public source had more advanced TNM stages at diagnosis and were less likely to have noninvasive papillary transitional-cell carcinoma. Within a 5-year follow-up period, median OS was not reached in either group. Funding source was significantly associated with OS in favor of private source (hazard ratio [HR], 1.72 [95% CI, 1.51 to 1.96];\n              <jats:italic toggle=\"yes\">P<\/jats:italic>\n              &lt; .001), even after adjustment for age, TNM stage, and educational level (HR, 1.41 [95% CI, 1.21 to 1.65];\n              <jats:italic toggle=\"yes\">P<\/jats:italic>\n              &lt; .001). The 5-year OS rate was 68.5% (95% CI, 68.5% to 68.5%) and 53.71% (95% CI, 53.7% to 53.7%) for private and public groups, respectively.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>Public source of funding was associated with a lower OS for bladder cancer. Much progress is required to ensure higher standards of health care focusing on patients treated at public sources.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1200\/go-24-00648","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T19:59:38Z","timestamp":1750967978000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":0,"title":["Survival According to Source of Treatment Funding in Bladder Cancer: Analysis of a Large Public Database From S\u00e3o Paulo, Brazil"],"prefix":"10.1200","author":[{"given":"Fernando C.","family":"Maluf","sequence":"first","affiliation":[{"name":"Hospital Israelita Albert Einstein, S\u00e3o Paulo, Brazil"},{"name":"Hospital Benefic\u00eancia Portuguesa de S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7385-5729","authenticated-orcid":true,"given":"Cintia S. K. S.","family":"de Oliveira","sequence":"additional","affiliation":[{"name":"Produtos Roche Qu\u00edmicos e Farmac\u00eauticos, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8012-3761","authenticated-orcid":true,"given":"Patr\u00edcia K.","family":"Ziegelmann","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"233","reference":[{"key":"e_1_3_6_2_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834"},{"key":"e_1_3_6_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s44197-022-00042-8"},{"key":"e_1_3_6_4_2","doi-asserted-by":"publisher","DOI":"10.1590\/s1677-5538.ibju.2019.0198"},{"key":"e_1_3_6_5_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21631"},{"key":"e_1_3_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30512-8"},{"volume-title":"NCCN Practice Guidelines in Oncology. Bladder Cancer \u2013 v.3.2023","author":"National Comprehensive Cancer Network","key":"e_1_3_6_7_2","unstructured":"National Comprehensive Cancer Network: NCCN Practice Guidelines in Oncology. Bladder Cancer \u2013 v.3.2023. http:\/\/www.nccn.org"},{"key":"e_1_3_6_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-40618-3"},{"key":"e_1_3_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2020.03.055"},{"key":"e_1_3_6_10_2","unstructured":"NCCN: National Comprehensive Cancer Network: NCCN practice guidelines in oncology. Bladder cancer\u2014version 3.2023\u2014may 25 2023 2023. http:\/\/www.nccn.org"},{"key":"e_1_3_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2017.04.086"},{"key":"e_1_3_6_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034442"},{"key":"e_1_3_6_13_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21820"},{"key":"e_1_3_6_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2309863"},{"key":"e_1_3_6_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2308849"},{"key":"e_1_3_6_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2312117"},{"key":"e_1_3_6_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-023-01273-8"},{"key":"e_1_3_6_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-014-0194-2"},{"key":"e_1_3_6_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djq495"},{"key":"e_1_3_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2018.04.160"},{"key":"e_1_3_6_21_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6190-3"},{"key":"e_1_3_6_22_2","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2018\/e430s"},{"key":"e_1_3_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31243-7"},{"key":"e_1_3_6_24_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-021-07376-2"},{"key":"e_1_3_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60054-8"},{"volume-title":"Dados e Indicadores do Setor","author":"Brasil. Ag\u00eancia Nacional de Sa\u00fade Suplementar","key":"e_1_3_6_26_2","unstructured":"Brasil. Ag\u00eancia Nacional de Sa\u00fade Suplementar: Dados e Indicadores do Setor. https:\/\/www.gov.br\/ans\/pt-br\/acesso-a-informacao\/perfil-do-setor\/dados-e-indicadores-do-setor"},{"key":"e_1_3_6_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-022-03289-z"},{"key":"e_1_3_6_28_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-13-0693"},{"key":"e_1_3_6_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/jha2.444"},{"key":"e_1_3_6_30_2","unstructured":"Maluf FC de Oliveira CSKS Ziegelmann PK: Impact of funding source on long-term outcomes in prostate cancer: Analysis of a large public database from Sao Paulo Brazil. JCO Glob Oncol 10.1200\/GO-24-00271"},{"key":"e_1_3_6_31_2","unstructured":"Funda\u00e7\u00e3o Oncocentro S\u00e3o Paulo. https:\/\/fosp.saude.sp.gov.br\/fosp\/diretoria-adjunta-de-informacao-e-epidemiologia\/rhc-registro-hospitalar-de-cancer\/banco-de-dados-do-rhc\/"},{"key":"e_1_3_6_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0b013e3181c1ea43"},{"key":"e_1_3_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2004.07.002"},{"key":"e_1_3_6_34_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-020-00995-7"},{"key":"e_1_3_6_35_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17114030"},{"key":"e_1_3_6_36_2","first-page":"e00004119","article-title":"[Healthcare trajectories and obstacles faced by women in a health region in Northeast Brazil]","volume":"35","author":"Galv\u00e3o JR","year":"2019","unstructured":"Galv\u00e3o JR, Almeida PF, Santos AMD, et al: [Healthcare trajectories and obstacles faced by women in a health region in Northeast Brazil]. Cad Saude Publica 35:e00004119, 2019","journal-title":"Cad Saude Publica"},{"key":"e_1_3_6_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30171-1"},{"key":"e_1_3_6_38_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-022-14199-1"},{"key":"e_1_3_6_39_2","volume-title":"DATASUS\u2014Departamento de Inform\u00e1tica do Sistema \u00danico de Sa\u00fade","author":"Brazilian Ministry of Health","year":"2024","unstructured":"Brazilian Ministry of Health: DATASUS\u2014Departamento de Inform\u00e1tica do Sistema \u00danico de Sa\u00fade. 2024"},{"key":"e_1_3_6_40_2","unstructured":"Brazilian Ministry of Health: SIGTAP\u2014Sistema de Gerenciamento da Tabela de Procedimentos Medicamentos e OPM do SUS Ministerio_da_Saude"},{"key":"e_1_3_6_41_2","unstructured":"Brazilian Ministry of Health: SIA\/SUS Manual de Bases T\u00e9cnicas da Oncologia\u2014Sistema de Informa\u00e7\u00f5es Ambulatoriais"},{"key":"e_1_3_6_42_2","doi-asserted-by":"publisher","DOI":"10.1590\/s1677-5538.ibju.2020.0658"},{"key":"e_1_3_6_43_2","article-title":"Dramatic impact of centralization and a multidisciplinary bladder cancer program in reducing mortality: The CABEM project","author":"Korkes F","unstructured":"Korkes F, Tim\u00f3teo F, Martins S, et al: Dramatic impact of centralization and a multidisciplinary bladder cancer program in reducing mortality: The CABEM project. JCO Glob Oncol 10.1200\/GO.21.00104","journal-title":"JCO Glob Oncol"},{"key":"e_1_3_6_44_2","doi-asserted-by":"publisher","DOI":"10.31744\/einstein_journal\/2020AO5628"}],"container-title":["JCO Global Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/GO-24-00648","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T19:59:43Z","timestamp":1750967983000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/GO-24-00648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1200\/GO-24-00648"],"URL":"https:\/\/doi.org\/10.1200\/go-24-00648","relation":{},"ISSN":["2687-8941"],"issn-type":[{"type":"electronic","value":"2687-8941"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"2024-12-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-18","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2400648"}}